High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
KIRKWOOD, J. M, IBRAHIM, J. G, SONDAK, V. K, RICHARDS, J, FLAHERTY, L. E, ERNSTOFF, M. S, SMITH, T. J, RAO, U, STEELE, M, BLUM, R. H
Published in Journal of clinical oncology (12.06.2000)
Published in Journal of clinical oncology (12.06.2000)
Get full text
Journal Article
Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials
FLAHERTY, L. E, ATKINS, M, SOROKIN, P, FISHER, R. I, APPEL, C, DU, W, SOSMAN, J, WEISS, G, CLARK, J. I, MARGOLIN, K, DUTCHER, J, GORDON, M. S, LOTZE, M, MIER, J
Published in Journal of clinical oncology (01.07.2001)
Published in Journal of clinical oncology (01.07.2001)
Get full text
Journal Article
Implications of Microscopic Satellites of the Primary and Extracapsular Lymph Node Spread in Patients With High-Risk Melanoma: Pathologic Corollary of Eastern Cooperative Oncology Group Trial E1690
RAO, U. N. M, IBRAHIM, J, FLAHERTY, L. E, RICHARDS, J, KIRKWOOD, J. M
Published in Journal of clinical oncology (15.04.2002)
Published in Journal of clinical oncology (15.04.2002)
Get full text
Journal Article
Weekly 1-hour infusion of paclitaxel: Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma
TRIVEDI, C, REDMAN, B, FLAHERTY, L. E, KUCUK, O, WEI DU, HEILBRUN, L. K, HUSSAIN, M
Published in Cancer (15.07.2000)
Published in Cancer (15.07.2000)
Get full text
Journal Article
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study
Meyskens, Jr, F L, Kopecky, K J, Taylor, C W, Noyes, R D, Tuthill, R J, Hersh, E M, Feun, L G, Doroshow, J H, Flaherty, L E, Sondak, V K
Published in JNCI : Journal of the National Cancer Institute (15.11.1995)
Published in JNCI : Journal of the National Cancer Institute (15.11.1995)
Get more information
Journal Article
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study
Margolin, K A, Liu, P Y, Flaherty, L E, Sosman, J A, Walker, M J, Smith, 3rd, J W, Fletcher, W S, Weiss, G R, Unger, J M, Sondak, V K
Published in Journal of clinical oncology (01.02.1998)
Published in Journal of clinical oncology (01.02.1998)
Get more information
Journal Article
A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma
Wallack, Marc K., Sivanandham, Muthukumaran, Balch, Charles M., Urist, Marshall M., Bland, Kirby I., Murray, Douglas, Robinson, William A., Flaherty, Lawrence E., Richards, Jon M., Bartolucci, Alfred A., Rosen, Les
Published in Cancer (01.01.1995)
Published in Cancer (01.01.1995)
Get full text
Journal Article
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials
Flaherty, L E, Unger, J M, Liu, P Y, Mertens, W C, Sondak, V K
Published in American journal of clinical oncology (01.12.1998)
Published in American journal of clinical oncology (01.12.1998)
Get more information
Journal Article
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin‐2 in metastatic malignant melanoma
Flaherty, Lawrence E., Redman, Bruce G., Martino, Silvana, Kraut, Michael, Valdivieso, Manuel, Robinson, William, Gonzalez, Rene, Rudolph, Alfred R.
Published in Cancer (01.06.1993)
Published in Cancer (01.06.1993)
Get full text
Journal Article
Oral etoposide in the treatment of hormone‐refractory prostate cancer
Hussain, Maha H., Pienta, Kenneth J., Redman, Bruce G., Cummings, Glenn D., Flaherty, Lawrence E.
Published in Cancer (01.07.1994)
Published in Cancer (01.07.1994)
Get full text
Journal Article
Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma
Flaherty, L E, Liu, P Y, Unger, J, Sondak, V K
Published in American journal of clinical oncology (01.12.1997)
Published in American journal of clinical oncology (01.12.1997)
Get more information
Journal Article
Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma : a southwest oncology group trial
MARGOLIN, K. A, LIU, P. Y, WEISS, G. R, SONDAK, V. K, UNGER, J. M, FLETCHER, W. S, FLAHERTY, L. E, URBA, W. J, HERSH, E. M, HUTCHINS, L. E, SOSMAN, J. A, SMITH, J. W
Published in Journal of cancer research and clinical oncology (04.05.1999)
Published in Journal of cancer research and clinical oncology (04.05.1999)
Get full text
Journal Article
Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial
Flaherty, L E, Liu, P Y, Fletcher, W S, Goodwin, J W, Balcerzak, S P, Daniels, D, Stephens, R L, Sondak, V K
Published in JNCI : Journal of the National Cancer Institute (03.06.1992)
Published in JNCI : Journal of the National Cancer Institute (03.06.1992)
Get more information
Journal Article
A phase I‐II study of dacarbazine in combination with outpatient interleukin‐2 in metastatic malignant melanoma
Flaherty, Lawrence E., Redman, Bruce G., Chabot, Guy G., Martino, Silvana, Gualdoni, Steven M., Heilbrun, Lance K., Valdivieso, Manuel, Bradley, Edward C.
Published in Cancer (01.06.1990)
Published in Cancer (01.06.1990)
Get full text
Journal Article
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)
Flaherty, L E, Liu, P Y, Mitchell, M S, Fletcher, W S, Walker, M J, Goodwin, J W, Stephens, R L, Sondak, V K
Published in American journal of clinical oncology (01.04.1996)
Published in American journal of clinical oncology (01.04.1996)
Get more information
Journal Article